Future Fund: Breakthrough - Now Open for Applications EMBARG

Future Fund: Breakthrough - Now Open for Applications EMBARGO 001


The
The new programme was revealed by the Chancellor of the Exchequer,
Rishi Sunak, during the budget speech this past spring. The £375 million scheme is designed to encourage private investors to co-invest with the government in high-growth firms.  This UK-wide programme will deliver the funding via
British Patient Capital, a subsidiary of the
British Business Bank.
The UK government believes that these innovative firms have the ability to grow rapidly and have a significant economic impact –  critical to the UK’s future prosperity and economic recovery.
Judith Hartley, CEO of British Patient Capital, commented:
“With many world-class universities and a strong track record in science and research, the UK is fertile ground for creating high-growth companies based on cutting edge technologies. Through the commercialisation of R&D, these transformative companies will  help accelerate the deployment of innovative breakthrough technologies that can transform major industries; develop new medicines; support the transition to a net zero economy and strengthen the UK’s position as a science superpower. Future Fund: Breakthrough will enable these R&D intensive companies to raise the patient capital they need to fuel the later stages of their growth, and in doing so, help ensure the UK is a world leader in the industries of the future.”

Related Keywords

United Kingdom , British , Judith Hartley , British Business Bank , Future Fund , Rishi Sunak , United Kingdom Wide , British Patient Capital , British Business , Patient Capital , ஒன்றுபட்டது கிஂக்டம் , பிரிட்டிஷ் , ஜூடித் ஹார்ட்லி , பிரிட்டிஷ் வணிக வங்கி , எதிர்கால நிதி , ரிஷி சுனக் , ஒன்றுபட்டது கிஂக்டம் பரந்த , பிரிட்டிஷ் நோயாளி மூலதனம் , பிரிட்டிஷ் வணிக , நோயாளி மூலதனம் ,

© 2025 Vimarsana